Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Panacea Biotec Ltd (PANACEABIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10148
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; and combinative vaccines, including Easyfive-TT (DTwP-HepB-Hib), Novohib (haemophilus typeb conjugate vaccine IP) and Polprotec (inactivated poliomyelitis vaccine). Its pharmaceutical formulations span the therapeutic areas of oncology, nephrology, pain management, diabetes management, and organ transplantation. The company also offers contract research and manufacturing services. Panacea operates research and development centers and manufacturing facilities. It has subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Ltd (PANACEABIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Licensing Agreements 18
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Equity Offering 20
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Acquisition 21
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd – Key Competitors 22
Panacea Biotec Ltd – Key Employees 23
Panacea Biotec Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Legal and Regulatory 26
Mar 09, 2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA 26
Oct 17, 2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd, Key Competitors 22
Panacea Biotec Ltd, Key Employees 23
Panacea Biotec Ltd, Other Locations 24
Panacea Biotec Ltd, Subsidiaries 24
Panacea Biotec Ltd, Joint Venture 25

List of Figures
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stellar Biotechnologies Inc (SBOT)-製薬・医療分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • OncoSil Medical Ltd (OSL):医療機器:M&Aディール及び事業提携情報
    Summary OncoSil Medical Ltd (OncoSil), formerly Neuro Discovery Ltd, is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • XERIS Pharmaceuticals Inc (XERS):医療機器:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Air Lease Corporation:企業の戦略・SWOT・財務分析
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Quilvest Wealth Management:企業の戦略・SWOT・財務分析
    Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務分析
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Muang Thai Life Assurance Public Company Limited:企業の戦略・SWOT・財務分析
    Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Matrix Service Co:企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kingfisher Plc:戦略・SWOT・企業財務分析
    Kingfisher Plc - Strategy, SWOT and Corporate Finance Report Summary Kingfisher Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Amara Holdings Ltd:戦略・SWOT・企業財務分析
    Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Amara Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Swadeshi Industrial Works Plc:企業の戦略・SWOT・財務情報
    Swadeshi Industrial Works Plc - Strategy, SWOT and Corporate Finance Report Summary Swadeshi Industrial Works Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Meril Life Sciences Pvt Ltd:製品パイプライン分析
    Summary Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. …
  • Environmental Tectonics Corporation:企業の戦略・SWOT・財務情報
    Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Litani River Authority:企業の戦略的SWOT分析
    Litani River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Copelouzos group-エネルギー分野:企業M&A・提携分析
    Summary Copelouzos group (Copelouzos) is an energy company that offers business development services. The company’s services include energy production and training, equipment supply, wastes management, natural gas, and concession and property services. It’s waste management services include residues …
  • Olympus Corporation:企業の戦略・SWOT・財務情報
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆